Pixium Vision Announces First Implantation and Activation of IRIS® II in Spain

PARIS & BARCELONA, Spain--(BUSINESS WIRE)--Regulatory News: Pixium Vision (Paris:PIX), a company developing innovative bionic vision systems with the intention to enable patients who have lost their sight to lead more independent lives, announces the first implantation and activation of IRIS® II in Spain. This implantation is part of Pixium Vision’s ongoing multi-centre clinical trial to assess the performance of IRIS® II which is supposed to provide a treatment to compensate for blindness. The